In 2009, Shijiazhuang Rainbowlabs Pharmaceutical Technology Co., Ltd., as a high-tech enterprise at the forefront of international advanced technologies, jointly designed, constructed and established the "Rainbowlabs Sino-European Joint Laboratory" with its European partner from Ireland in full compliance with the latest international standards.

Through continuous improvement of its quality management system and testing capabilities, the laboratory has successfully obtained certifications from the U.S. FDA, Health Canada and China CNAS, becoming China's first biomedical public technical service platform to simultaneously possess all these three laboratory accreditations, which has established its leading position in the global pharmaceutical testing field.